Chemotherapy-Induced Peripheral Neuropathy Clinical Trials
To determine eligibility for any of the studies, a screening visit may include:
Are you ready to make a difference? Our CIPN trial offers you the chance to be at the forefront of scientific advancement. By joining us, you can play a pivotal role in combating a debilitating side effect of cancer treatment.


Why?
Chemotherapy-induced peripheral neuropathy is a major challenge that affects millions of individuals worldwide, impairing their ability to perform daily tasks, maintain mobility, and enjoy an independent life. Treating this condition is crucial because it directly improves patients' quality of life, helping them regain sensory and motor functions and reducing long-term discomfort.
Joining A Clinical Trial At Conquest Research
Let’s take a closer look at what chemotherapy-induced peripheral neuropathy clinical trials entail and how you can benefit.
Chemotherapy-Induced Peripheral Neuropathy Clinical Trials FAQs


Participate in a Chemotherapy-Induced Peripheral Neuropathy Clinical Trial
Join us in our mission to improve lives. If you are interested in participating in a chemotherapy-induced peripheral neuropathy clinical trial, fill out the form today to see if you qualify.
